vs

Side-by-side financial comparison of FEMASYS INC (FEMY) and Iveda Solutions, Inc. (IVDA). Click either name above to swap in a different company.

FEMASYS INC is the larger business by last-quarter revenue ($813.4K vs $626.0K, roughly 1.3× Iveda Solutions, Inc.). Iveda Solutions, Inc. runs the higher net margin — -258.6% vs -485.7%, a 227.1% gap on every dollar of revenue. On growth, FEMASYS INC posted the faster year-over-year revenue change (39.9% vs -64.1%). Over the past eight quarters, FEMASYS INC's revenue compounded faster (73.2% CAGR vs 34.4%).

Femasys Inc. is a medical technology firm specializing in developing and commercializing minimally invasive diagnostic and therapeutic devices for women's health. Its core products address unmet clinical needs in fertility care, gynecology and obstetrics, serving healthcare providers and patients mainly across North American and European markets.

Iveda Solutions, Inc. is a technology provider specializing in cloud-based AI video surveillance, IoT-enabled smart sensing, and integrated smart city solutions. It serves public sector, enterprise, and education clients across North America and Asia, with core offerings covering remote security monitoring, smart facility management, and real-time data analysis tools for public safety use cases.

FEMY vs IVDA — Head-to-Head

Bigger by revenue
FEMY
FEMY
1.3× larger
FEMY
$813.4K
$626.0K
IVDA
Growing faster (revenue YoY)
FEMY
FEMY
+103.9% gap
FEMY
39.9%
-64.1%
IVDA
Higher net margin
IVDA
IVDA
227.1% more per $
IVDA
-258.6%
-485.7%
FEMY
Faster 2-yr revenue CAGR
FEMY
FEMY
Annualised
FEMY
73.2%
34.4%
IVDA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FEMY
FEMY
IVDA
IVDA
Revenue
$813.4K
$626.0K
Net Profit
$-4.0M
$-1.6M
Gross Margin
62.7%
3.6%
Operating Margin
-568.3%
-262.7%
Net Margin
-485.7%
-258.6%
Revenue YoY
39.9%
-64.1%
Net Profit YoY
22.9%
-7.1%
EPS (diluted)
$0.02
$-0.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FEMY
FEMY
IVDA
IVDA
Q4 25
$813.4K
$626.0K
Q3 25
$729.4K
$1.7M
Q2 25
$409.3K
$1.5M
Q1 25
$341.3K
$1.5M
Q4 24
$581.6K
$1.7M
Q3 24
$554.9K
$2.4M
Q2 24
$221.5K
$1.5M
Q1 24
$271.1K
$346.8K
Net Profit
FEMY
FEMY
IVDA
IVDA
Q4 25
$-4.0M
$-1.6M
Q3 25
$-4.2M
$-221.3K
Q2 25
$-4.6M
$-564.2K
Q1 25
$-5.9M
$-793.7K
Q4 24
$-5.1M
$-1.5M
Q3 24
$-5.4M
$-581.4K
Q2 24
$-4.7M
$-599.0K
Q1 24
$-3.6M
$-1.3M
Gross Margin
FEMY
FEMY
IVDA
IVDA
Q4 25
62.7%
3.6%
Q3 25
59.7%
31.3%
Q2 25
61.4%
29.1%
Q1 25
65.6%
19.5%
Q4 24
66.9%
11.9%
Q3 24
65.6%
17.1%
Q2 24
67.0%
32.7%
Q1 24
67.3%
52.5%
Operating Margin
FEMY
FEMY
IVDA
IVDA
Q4 25
-568.3%
-262.7%
Q3 25
-500.9%
-13.0%
Q2 25
-941.1%
-34.8%
Q1 25
-1600.1%
-56.7%
Q4 24
-812.0%
-87.3%
Q3 24
-922.4%
-25.4%
Q2 24
-2023.7%
-39.7%
Q1 24
-1277.1%
-384.1%
Net Margin
FEMY
FEMY
IVDA
IVDA
Q4 25
-485.7%
-258.6%
Q3 25
-575.1%
-13.4%
Q2 25
-1120.5%
-36.9%
Q1 25
-1727.9%
-53.8%
Q4 24
-881.0%
-86.7%
Q3 24
-974.7%
-24.2%
Q2 24
-2115.1%
-39.0%
Q1 24
-1327.5%
-371.9%
EPS (diluted)
FEMY
FEMY
IVDA
IVDA
Q4 25
$0.02
$-0.33
Q3 25
$-0.10
$-0.07
Q2 25
$-0.16
$-0.20
Q1 25
$-0.23
$-0.28
Q4 24
$-0.23
$-0.60
Q3 24
$-0.24
$-0.27
Q2 24
$-0.21
$-0.30
Q1 24
$-0.17
$-0.64

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FEMY
FEMY
IVDA
IVDA
Cash + ST InvestmentsLiquidity on hand
$9.3M
$5.2M
Total DebtLower is stronger
$393.4K
Stockholders' EquityBook value
$5.9M
$4.8M
Total Assets
$20.7M
$6.4M
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FEMY
FEMY
IVDA
IVDA
Q4 25
$9.3M
$5.2M
Q3 25
$4.6M
$3.3M
Q2 25
$3.2M
$1.6M
Q1 25
$3.8M
$2.5M
Q4 24
$3.5M
$2.6M
Q3 24
$7.6M
$3.6M
Q2 24
$13.5M
$2.9M
Q1 24
$17.8M
$3.9M
Total Debt
FEMY
FEMY
IVDA
IVDA
Q4 25
$393.4K
Q3 25
$306.4K
Q2 25
$365.3K
Q1 25
$340.8K
Q4 24
$376.2K
Q3 24
$545.9K
Q2 24
$564.0K
Q1 24
$480.0K
Stockholders' Equity
FEMY
FEMY
IVDA
IVDA
Q4 25
$5.9M
$4.8M
Q3 25
$4.6M
$3.8M
Q2 25
$1.5M
$1.5M
Q1 25
$2.0M
$1.7M
Q4 24
$2.3M
$2.5M
Q3 24
$6.0M
$4.1M
Q2 24
$11.3M
$2.8M
Q1 24
$15.6M
$3.3M
Total Assets
FEMY
FEMY
IVDA
IVDA
Q4 25
$20.7M
$6.4M
Q3 25
$16.3M
$5.8M
Q2 25
$13.8M
$4.4M
Q1 25
$13.3M
$4.5M
Q4 24
$12.4M
$5.2M
Q3 24
$15.6M
$9.1M
Q2 24
$20.3M
$6.8M
Q1 24
$24.4M
$6.6M
Debt / Equity
FEMY
FEMY
IVDA
IVDA
Q4 25
0.08×
Q3 25
0.08×
Q2 25
0.25×
Q1 25
0.20×
Q4 24
0.15×
Q3 24
0.13×
Q2 24
0.20×
Q1 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FEMY
FEMY
IVDA
IVDA
Operating Cash FlowLast quarter
$-4.2M
$-252.4K
Free Cash FlowOCF − Capex
$-4.3M
FCF MarginFCF / Revenue
-531.7%
Capex IntensityCapex / Revenue
17.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-19.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FEMY
FEMY
IVDA
IVDA
Q4 25
$-4.2M
$-252.4K
Q3 25
$-5.4M
$-317.0K
Q2 25
$-4.4M
$-1.3M
Q1 25
$-4.8M
$-126.0K
Q4 24
$-5.1M
$-889.8K
Q3 24
$-5.5M
$-1.2M
Q2 24
$-4.3M
$-999.7K
Q1 24
$-4.6M
$-1.3M
Free Cash Flow
FEMY
FEMY
IVDA
IVDA
Q4 25
$-4.3M
Q3 25
$-5.6M
Q2 25
$-4.4M
Q1 25
$-4.9M
Q4 24
$-5.2M
$-889.8K
Q3 24
$-5.9M
$-1.5M
Q2 24
$-4.5M
$-1.1M
Q1 24
$-4.6M
$-1.5M
FCF Margin
FEMY
FEMY
IVDA
IVDA
Q4 25
-531.7%
Q3 25
-765.3%
Q2 25
-1086.6%
Q1 25
-1424.7%
Q4 24
-890.9%
-51.1%
Q3 24
-1060.1%
-64.1%
Q2 24
-2035.8%
-72.6%
Q1 24
-1708.6%
-427.3%
Capex Intensity
FEMY
FEMY
IVDA
IVDA
Q4 25
17.2%
Q3 25
26.6%
Q2 25
23.0%
Q1 25
28.3%
Q4 24
18.4%
0.0%
Q3 24
73.5%
12.5%
Q2 24
82.4%
7.5%
Q1 24
23.8%
54.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons